We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00735085
Recruitment Status : Terminated (This study was stopped 20 May 2010 due to strategic considerations)
First Posted : August 14, 2008
Last Update Posted : September 21, 2011
Quintiles, Inc.
Information provided by (Responsible Party):
Abbott ( Abbott Products )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : August 2010
  Study Completion Date : August 2010
  Certification or Request for Extension to Delay Results Submission: September 9, 2011